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INTRODUCTION
Myopericarditis is an inflammation of the myocardial and the 
pericardial layers of the heart.1 Acute myopericarditis commonly 
is caused by viral illness, however less commonly, it may be caused 
by non-infectious etiologies. Myocarditis, which is an inflamma-
tion of the myocardium, can be divided into acute, sub-acute, or 
chronic. Based on the histology, these can be classified as active or 
borderline myocarditis by the Dallas criteria for interpretation of 
endomyocardial biopsy. The disease may either affect a focal part of 
the myocardium or have diffuse involvement. 
The incidence of myocarditis and pericarditis is 22 - 27.7/100,000 
and the incidence of myopericarditis is even less.2 Myocarditis is 
reported to be the reason for 0.5% to 3.5% of the heart failure hos-
pitalizations all over the world.3 While myocarditis is a well-known 
presentation, focal myopericarditis is rare. Focal myopericarditis 
can mimic an acute ST-elevation myocardial infarction, which often 
requires prompt treatment with invasive angiography. This identical 
presentation makes diagnosis of focal myopericarditis difficult, and 
thus, clinical suspicion is essential for diagnosis. With growing popu-
lation presenting as MI from coronary plaque ruptures, the diagnosis 
of focal myopericarditis remains challenging. Its clinical presentation 
may vary from subtle to life-threatening to even death. 
We present a Caucasian female with chest pain and ST-elevation 
on electrocardiogram (ECG) who was found to have focal myoperi-
carditis.
CASE REPORT
An 18-year-old previously healthy female presented to the emer-
gency room for crushing chest pain. She woke up at 0800 with 
mid-sternal chest pain radiating to her back and bilateral arms with 
associated symptoms of shortness of air at rest. She denied cough, 
rhinorrhea, nasal congestion, nausea, vomiting, diarrhea, or dia-
phoresis. She reported no change in quality of pain with position or 
inspiration. She did not have any past surgical history or history of 
premature coronary artery disease in her family. The patient smoked 
1 - 2 cigarettes per day, but denied illicit drug or alcohol abuse.
Physical examination in the emergency room was notable for 
regular heart rhythm without murmurs, gallops, or rubs. She was 
afebrile with a heart rate of 74 bpm, respiratory rate of 12, blood pres-
sure of 137/93 mmHg, and oxygen saturation was 99% on room air. 
She had no peripheral edema or jugular venous distention. Her lungs 
were clear to auscultation. An electrocardiogram (ECG) on presen-
tation showed ST-elevation in the inferior wall distribution (Leads II, 
III, and aVF) with non-specific PR interval changes (Figure 1). Tro-
ponin I was 0.06 ng/mL on admission (reference normal <0.07ng/
mL), which peaked to 22.88 ng/mL at 12 hours after admission. CT-
angiography of the chest ruled out aortic dissection and pulmonary 
embolism. Echocardiogram at bedside revealed inferior wall hypoki-
nesis, which was concerning for a plaque rupture, thus, she was taken 
for cardiac catheterization while the troponin was trending up (from 
0.06 to 1.06 ng/mL four hours after admission).
Figure 1. Admission ECG showing ST-segment elevation in inferior leads II, 
III, and aVF (arrows).
Cardiac catheterization revealed patent coronary arteries with 
hypokinesis of the inferior wall on left ventriculogram (Figure 2). 
Echocardiogram showed left ventricular ejection fraction of 55 - 
60% with mild degree of hypokinesis in the inferior wall. Complete 
blood count, renal function panel, thyroid function studies, erythro-
cyte sedimentation rate, C-reactive protein, and urine drug screens 
were normal. Fasting lipid panel showed elevated total cholesterol 
at 213 mg/dL and low density lipoprotein (LDL) at 136 mg/dL with 
a normal high density lipoprotein (HDL) at 66 mg/dL. Because of a 
negative heart catheterization with ST segment elevation on ECG 
and troponin elevation, coronary vasospasm and myopericarditis 
were high among the differential diagnosis. Troponin I trended down 
after the 12-hour peak, and the patient was stable with chest pain 
resolved. She was discharged after 24 hours to have a close outpatient 
follow-up for a cardiac MRI (CMR). With the exception of nonste-
roidal anti-inflammatories as needed, no new medications, including 
anticoagulants, were prescribed at the time of discharge.
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Figure 2. Angiography of the left heart vessels shows patent right (top left 
image) and left coronary (top right and lower images) arteries and branches.
At two-week follow-up, the patient was symptom-free with a 
normal ECG (Figure 3). To support the clinical diagnosis of myo-
pericarditis and rule out other possible causes of non-ischemic 
cardiomyopathy, she underwent a cardiac magnetic resonance 
imaging (CMR) as an outpatient, which revealed hypokinesis of the 
lateral and inferior wall of the left ventricle apex with epicardial and 
transmural delayed enhancement, suggestive of focal myopericarditis 
(Figure 4).
Figure 3. A 2-week follow-up ECG showing resolution of the ST-segment 
elevation.
DISCUSSION
 Given the patient’s age, drug abuse causing vasospasm, aortic 
dissection, and thromboembolic causes were high on the differen-
tial diagnoses, but these were ruled out by history, vital signs, and 
administration of sublingual nitroglycerin. Myocarditis and pericar-
ditis were low on the differential as they typically present with diffuse 
ST segment changes on ECG. Clinical presentation is the key in this 
particular diagnosis; however in our patient, she denied having any 
prodromal viral or gastrointestinal illness which made it more diffi-
cult. Of note, our patient remained afebrile during the entirety of her 
hospitalization. Several factors can trigger coronary vasospasm, such 
as use of cocaine, amphetamine, marijuana, chemotherapy drugs, 
over-the-counter medications, and antibiotics. Our patient did not 
have exposure to any of these. 
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Figure 4. CMR showed epicardial and transmural delayed enhancement, 
suggestive of focal myopericarditis (arrow). 
 Coronary artery spasm is a multifactorial disease with underlying 
mechanism that is still poorly understood.4 Typically, coronary artery 
spasm will reveal stenosis during cardiac catheterization during both 
systole and diastole and responds to calcium channel blockers and 
nitroglycerin. Myopericarditis typically follows history of fever. A 
history of upper respiratory infection symptoms often helps, but its 
absence does not rule out the disease. Ultimately, to differentiate the 
two, diagnostic tools such as enhanced imaging techniques like CMR 
and/or invasive coronary angiography come into play to make the 
correct diagnosis.
 ST-elevation myocardial infarction is the most important differen-
tial diagnosis of focal myopericarditis among others.5 Myopericarditis 
shows a characteristic pattern of contrast enhancement on CMR, 
which originates primarily from the epicardium, sparing the suben-
docardial layer. Myopericarditis need not always have elevated ESR 
and CRP as they are only positive in 60% of the cases.6 Indications 
for endomyocardial biopsy (EMB) include new-onset heart failure 
of less than two weeks duration associated with hemodynamic com-
promise which is unexplained, new-onset heart failure of two weeks 
to three months duration associated with a dilated left ventricle, new 
ventricular arrhythmias with no certain explanation, Mobitz type II 
second-degree atrioventricular (AV) block, third-degree atrioven-
tricular (AV) block, or refractory heart failure.7 Biopsy is indicated in 
these instances to evaluate for possible rare diagnoses such as giant 
cell myocarditis (where early diagnosis prompts potential preparation 
for transplantation), lymphocytic myocarditis, sarcoidosis (response 
to restrictive cardiomyopathy from steroids which are not otherwise 
used for routine heart failure treatment), dilated cardiomyopathy 
due to eospinophilia (high-dose steroid responsive), amyloidosis, and 
hemochromatosis. These different etiologies have unconventional 
heart failure treatment and present acutely, thus EMB may help in 
this situation. Dallas Criteria (histologic criteria) have an overall 
low diagnostic yield according to one case series of 1,230 patients.8
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 Diagnosis of myopericarditis is empiric and made on clinical pre-
sentation. ECG changes, elevated cardiac enzymes, lack of epicardial 
coronary artery disease, and abnormal CMR support the diagnosis.9 
Myopericarditis shows a characteristic pattern of contrast enhance-
ment on CMR, which originates from the epicardium, sparing the 
subendocardial layer.10 Positron emission tomography (PET) also 
can be used to assess for occult inflammation.11 Indications for endo-
myocardial biopsy exist, but the sensitivity and specificity of EMB 
are approximately 60% and 80%, respectively, and autopsy is the 
gold standard.12 A lower sensitivity of 35% has been noted when a 
clinical and functional gold standard is used.13 Treatment is support-
ive for myopericarditis and case-dependent. Clinicians must have 
a high clinical suspicion for the diagnosis of myopericarditis with 
elevated cardiac enzymes and ST elevation in absence of coronary 
artery disease.
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